-
Product Insights
Aros G2 Biopower Plant
Aros G2 Biopower Plant is a biopower project located in Vastmanland, Sweden. The project is owned by Malarenergi AB. The project came online in 1963. Empower your strategies with our Aros G2 Biopower Plant report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or...
-
Product Insights
Nymolla Mill Plant G1,G2
Nymolla Mill Plant G1,G2 is a biopower project located in Scania, Sweden. The project is owned by Stora Enso Nymolla AB. The project came online in 1962. Empower your strategies with our Nymolla Mill Plant G1,G2 report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be...
-
Product Insights
Cemig SIM G2 Apolo Brazil Solar PV Park
Cemig SIM G2 Apolo Brazil Solar PV Park is a solar PV project located in Minas Gerais, Brazil. The project is owned and developed by Apolo Empreendimentos e Energia Ltda; G2 Energia e Empreendimentos Imobiliarios Ltda. The project is currently active. Empower your strategies with our Cemig SIM G2 Apolo Brazil Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tezepelumab in Churg-Strauss Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tezepelumab in Churg-Strauss Syndrome report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tezepelumab in Churg-Strauss Syndrome Drug Details: Tezepelumab-ekko (Tezspire) is a first-in-class...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tezepelumab in Cat Allergy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tezepelumab in Cat Allergy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tezepelumab in Cat Allergy Drug Details: Tezepelumab-ekko (Tezspire) is a first-in-class...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Tezepelumab in Rhinosinusitis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tezepelumab in Rhinosinusitis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tezepelumab in Rhinosinusitis Drug Details: Tezepelumab-ekko (Tezspire) is a first-in-class human monoclonal antibody...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lutetium Lu 177 Dotatate in Pheochromocytoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lutetium Lu 177 Dotatate in Pheochromocytoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lutetium Lu 177 Dotatate in Pheochromocytoma Drug Details: Lutetium Lu-177...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tezepelumab in Chronic Urticaria Or Hives
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tezepelumab in Chronic Urticaria Or Hives report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tezepelumab in Chronic Urticaria Or Hives Drug Details: Tezepelumab-ekko...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lutetium Lu 177 Dotatate in Neuroblastoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lutetium Lu 177 Dotatate in Neuroblastoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Lutetium Lu 177 Dotatate in Neuroblastoma Drug Details: Lutetium Lu-177...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Erenumab in Rosacea
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Erenumab in Rosacea report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Erenumab in Rosacea Drug Details: Erenumab (Aimovig, Aerinex, Pasurta, Glaseeq) is a human immunoglobulin...